Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest National Comprehensive Cancer Network Stories

2014-04-08 23:04:19

Patricia Goldsmith to lead CancerCare, 70-year-old national nonprofit for people coping with cancer New York, NY (PRWEB) April 08, 2014 CancerCare® (including the CancerCare Co-Payment Assistance Foundation), the leading national nonprofit organization providing free, professional support services to anyone affected by cancer, announced today the appointment of Patricia J. Goldsmith as Chief Executive Officer, effective May 5, 2014. The announcement comes as the organization...

2014-02-24 12:27:05

CAMBRIDGE, Mass., Feb. 24, 2014 /PRNewswire/ -- KEW Group Inc. (KEW), a privately held oncology services company located in Cambridge, Mass., announced today the recent closing of a private round of financing with Cardinal Health (NYSE: CAH) and The Bolyston Street Group. KEW is focused on providing state-of-the-art diagnostic services to help inform and advance community oncologists' treatment decisions for their patients. "We believe there is a strong need to arm community...

2014-01-30 23:22:47

The Advanced Practitioner Society for Hematology and Oncology (APSHO) launches at the First JADPRO Live: Transforming Oncology Practice conference. St. Petersburg, FL (PRWEB) January 30, 2014 Harborside Press announces the launch of the Advanced Practitioner Society for Hematology and Oncology (APSHO), a new organization focused on meeting the unique educational and professional needs of the advanced practitioner in hematology and oncology. The formation of the Society was announced on...

2014-01-07 08:30:40

- Agreement to Distribute Oncotype DX(R) in Australia and New Zealand MELBOURNE, Australia, Jan. 7, 2014 /PRNewswire/ -- Australian women will potentially have greater access to the only genomic test validated to predict whether patients with early-stage invasive breast cancer would benefit from chemotherapy, following an agreement between Specialised Therapeutics Australia (STA) and Genomic Health, Inc. (NASDAQ: GHDX). STA has struck an agreement to represent the important...

2013-12-16 20:21:22

SALT LAKE CITY, Dec. 16, 2013 /PRNewswire/ -- The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II)...

2013-10-29 23:29:58

The First Annual JADPRO LIVE Conference to feature a special panel discussion on the changing role of advanced practitioners in oncology, today and tomorrow. Cold Spring Harbor, NY (PRWEB) October 29, 2013 Harborside Press is pleased to announce its first annual three-day conference, JADPRO LIVE: Transforming Oncology Practice. The conference brings Harborside’s popular peer-reviewed publication, the Journal of the Advanced Practitioner in Oncology (JADPRO), to a live, interactive...

2013-10-24 16:25:50

IMRT use is 2 1/2 times greater when self-referral's financial incentives are involved FAIRFAX, Va., Oct. 24, 2013 /PRNewswire-USNewswire/ -- A comprehensive review of Medicare claims for more than 45,000 patients from 2005 through 2010 found that nearly all of the 146 percent increase in intensity- modulated radiation therapy (IMRT) for prostate cancer among urologists with an ownership interest in the treatment was due to self-referral, according to new research, "Urologists' Use of...

2013-10-01 08:32:30

Maker of BREVAGen(TM) breast cancer predictive risk test makes donation to Komen for the Cure in honor of Cyndi Pierre's courage to learn more and share her experience ROGERS, Ark., Oct. 1, 2013 /PRNewswire/ -- At age 44, Cyndi Pierre believed that her family history of breast cancer - her mother and sister were both diagnosed - put her at risk for developing the disease, too. She ate healthy, exercised, and saw her doctor regularly for mammograms, which were normal. Pierre even...

2013-09-23 13:58:38

Cancer patients receiving radiotherapy (RT) who are potentially suffering from depression can be effectively identified by a two-item questionnaire, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting. The Radiation Oncology Therapy Group (RTOG) Community Clinical Oncology Program (CCOP)-supported multi-institutional study screened 455 patients receiving radiation treatment at 37 centers around the U.S. Participants in the...

2013-08-05 23:04:19

A new drug is being developed to help patients suffering from the undertreated cancer mesothelioma LOS ANGELES (PRWEB) August 05, 2013 Baron and Budd is proud to announce the Food and Drug Administration’s approval of a new drug to be used for the treatment of the rare cancer, mesothelioma, that occurs because of exposure to asbestos. This new drug is called VS-6036, or defactinib, and is a cancer-stem-cell inhibitor that is manufactured by Verastem Inc. (VSTM)....